OXFORD BIOMEDICA (OXB): MODERATED CHART AND DISCUSSION THREAD

don't know if it has been posted, but it clearly states that for the new licence agreement...Under the terms of the
amended agreement, Oxford BioMedica will receive a one-time undisclosed payment
from the licensee. Further financial details were not disclosed.

So 'we' wont receive annual license agreement fees...BUT the fact that more companies are using the technique in their research will lead to a larger pipeline of products...and this is a licensing agreement for research...any actual use of the technique in drug delivery would result in further payments...imho